Finance

Lists
CGTX:NASDAQ
Cognition Therapeutics Inc
$1.05
0.00%
(0.00) 1D
$1.04
-0.95% (-0.0100)
Pre-market
Closed: Sep 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Mkt. cap
99.85M
Avg. vol.
492.46K
Volume
227.00
52-wk high
$2.67
52-wk low
$0.55
EPS
-$0.20
Beta
1.79
Shares outstanding
95.09M
No. of employees
14
Mkt. cap
99.85M
Avg. vol.
492.46K
Volume
227.00
52-wk high
$2.67
52-wk low
$0.55
EPS
-$0.20
Beta
1.79
Shares outstanding
95.09M
No. of employees
14
About Cognition Therapeutics Inc
CEO-
Employees14
FoundedJan 1, 2007
Headquarters-
SectorPharmaceutical industry
Websitecogrx.com
Analyst ratings
Based on 1 analyst giving stock ratings to CGTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CGTX in the last 3 months
Highest
Current $1.05
$3.00 (+185.71%)
Average
$3.00 (+185.71%)
Lowest
$3.00 (+185.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$3.00
+185.7%
08/13/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$4.00
+281%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
$3.00
+185.7%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.77M
11.15M
6.12M
5.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.60M
2.52M
2.70M
2.64M
Operating expense
6.38M
13.67M
8.82M
7.74M
Total operating expenses
6.38M
13.67M
8.82M
7.74M
Operating income
-6.38M
-13.67M
-8.82M
-7.74M
Other non operating income
1.44M
10.33M
4.25M
3.81M
EBT including unusual items
-4.93M
-3.34M
-4.57M
-3.93M
EBT excluding unusual items
-4.93M
-3.34M
-4.57M
-3.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.93M
-3.34M
-4.57M
-3.93M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-0.02
-0.05
-0.04
Interest and investment income
-
-
-
-
Interest expense
-
-5.00K
-5.00K
-3.00K
Net interest expenses
-
-5.00K
-5.00K
-3.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.36M
-13.66M
-8.81M
-7.73M
Gain or loss from assets sale
-
41.00K
5.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps